Skip to content

Clinical trials

Phase 2 Peripheral Vascular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Vascular Diseases Phase: Phase 2 Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20035
20041
20053
20064
20072
20085
20102
20111
20122
20141
20171
20181
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated5
Unknown status4
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AnGes USA, Inc.2
Valentis2
ARCA Biopharma, Inc.1
ActivBiotics1
Angiogenix1
AstraZeneca1
Bayer1
Beijing Northland Biotech. Co., Ltd.1
Biopure Corporation1
Biotronik, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Vascular Diseases30
Chronic Limb-Threatening Ischemia12
Peripheral Arterial Disease12
Intermittent Claudication7
Arterial Occlusive Diseases6
Ischemia5
Atherosclerosis2
Cardiovascular Diseases2
Coronary Artery Disease2
Ulcer2

Trials

Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.